MedGAN:优化生成对抗网络与图形卷积网络,用于新型分子设计
Bruno Macedo1,2, Inês Ribeiro Vaz3,4,5, Tiago Taveira Gomes3,4,6,7
1Faculty of Medicine, University of Porto, Porto, Portugal. up200601848@edu.med.up.pt.
Scientific reports
|January 12, 2024
概括
生成型人工智能 (AI) 通过生成新的类分子来优化药物发现. 深度学习模型MedGAN成功创建了数千种独特的类似药物的化合物,进步了计算药物设计.
科学领域:
- 计算化学是一种计算化学.
- 药品化学 药品化学 是一个
- 人工智能的人工智能是人工智能.
背景情况:
- 对新药的需求需要先进的药物发现工具.
- 生成性人工智能提供了一种有前途的方法,可以加速识别新的分子结构.
研究的目的:
- 优化和微调MedGAN,这是一个深度学习模型,用于生成新的氨酸支架分子.
- 评估产生的分子的药物相似性,包括药理动力学,毒性和合成可访问性.
主要方法:
- 利用瓦斯斯坦的生成对抗网络和图形卷积网络进行分子生成.
- 执行过度参数调整和对生成的分子进行严格的评估.
- 专注于产生具有特定支架的分子,如诺林.
主要成果:
- 优化的MedGAN模型产生了25%的有效分子,其中92%是氨酸.
- 生成的分子呈现出高度的新性 (93%) 和独特性 (95%),保留了性和原子电荷.
- 成功生成了4831种具有良好的药物状性质的新奇奇诺林分子.
结论:
- 像MedGAN这样的深度学习模型可以有效地产生新的,类似药物的分子.
- 模型性能受到激活函数,优化器和分子结构等因素的影响.
- 这项工作增强了AI在计算药物设计和发现中的应用.
相关概念视频
Predicting Molecular Geometry
34.3K
VSEPR Theory for Determination of Electron Pair Geometries
34.3K
Structure-Activity Relationships and Drug Design
726
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
726
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)
1.9K
Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
1.9K


